Toggle Nav

PP 2 (AG 1879)

Catalog No.
A8216
Src-family kinases inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$66.00
In stock
5mg
$60.00
In stock
10mg
$110.00
In stock
25mg
$180.00
In stock

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

PP2 is a selective inhibitor of Src family with IC50 value of 4 nM and 5 nM for Lck and Fyn, respectively [1].

Src is a tyrosine kinase and contains 9 members: c-Src (this protein), Yes, Fyn, Fgr, Yrk, Lyn, Blk, Hck, and Lck [1].

PP2 is a potent Src family inhibitor that plays an important role in the cancer and is regarded as a promising target for treatment. When tested with human glioma cell line U251 spheroids in 3-D model, PP2 inhibited the cell invasion in a dose-dependent manner (2.5 μM, 10μM). And treated monolayer U251 cells with PP2 (10μM) decreased cell proliferation rate by inhibiting Src [2]. In human T cells, PP2 showed inhibition on anti-CD3-induced tyrosine phosphorylation by inhibiting Lck and Fyn that involved in the early T cell signal transduction [1].

In Sprague-Dawley rat model injected with urethane and after some needed treatment to perform research and record data, pretreatment with PP2 (50M, 10μL it) reversed the reflex potentiation, as well as Src kinase and NR2B phosphorylation by inhibiting Src family [3].

It is also reported that PP2 inhibits ZAP-70, JAK2 and EGF-R with IC50 value of >100 μM, >50 μM, and 480 nM, respectively [1].

References:
[1].  Hanke, J.H., et al., Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem, 1996. 271(2): p. 695-701.
[2].  Angers-Loustau, A., et al., SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions. Mol Cancer Res, 2004. 2(11): p. 595-605.
[3].  Wu, H.C., et al., EphrinB2 induces pelvic-urethra reflex potentiation via Src kinase-dependent tyrosine phosphorylation of NR2B. Am J Physiol Renal Physiol, 2011. 300(2): p. F403-11.

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageDesiccate at 4°C
M.Wt301.78
Cas No.172889-27-9
FormulaC15H16ClN5
Solubility≥15.1mg/mL in DMSO, ≥20.05 mg/mL in EtOH with ultrasonic,insoluble in H2O
Chemical Name1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine
SDFDownload SDF
Canonical SMILESCC(C)(C)N1C2=C(C(=N1)C3=CC=C(C=C3)Cl)C(=NC=N2)N
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Protocol

Cell experiment [1]:

Cell lines

Human glioblastoma cell line U251

Preparation method

Soluble in DMSO > 15.1mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

10μmol/L, 4days for cell proliferation assays; 5μmol/L, 1min for fluorescent time-lapse videomicroscopy images

Applications

A decreased proliferation appeared in the glioma cell cultures treated with 10μmol/L PP2, suggesting thatinhibition of Src family kinase activity in glioma cells resulted in an exit from the cell cycle in monolayers. PP2 caused the disappearance of peripheral membrane ruffles within minutes.

Animal experiment [2]:

Animal models

Female Sprague-Dawley rats

Dosage form

50 μM, 10 μl, intrathecal injection

Application

Pretreatment with PP2 exhibited no effects on the TS(test stimulation)-evoked baseline reflex activity, it prevented ephrinB2-dependent reflex potentiation by decreasing the mean spike count evoked by the TS.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Angers-Loustau A1, Hering R, et al, SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions. Mol Cancer Res, 2004. 2(11): p. 595-605.

[2]. Wu HC1, Chang CH, et al, EphrinB2 induces pelvic-urethra reflex potentiation via Src kinase-dependent tyrosine phosphorylation of NR2B. Am J Physiol Renal Physiol, 2011. 300(2): p. F403-11.

Biological Activity

Description PP2 is an inhibitor of Src family kinase.
Targets LCK Fyn EGFR JAK2 ZAP70  
IC50 4 nM 5 nM 480 nM >50 μM >100 μM  

Quality Control

Chemical structure

PP 2

Related Biological Data

PP 2